Results for “”

Entry Author Date Location
Why Spark and Watchdog ICER Don’t See Eye-to-Eye on $850K Gene Therapy 01/22/18 National
Bio Roundup: Spark’s Road Ahead, Juno Rumors, Merck’s Big Day & More 01/19/18 National
Spark CEO Marrazzo on Gene Therapy Pricing & Paving the Way for the Field 01/12/18 National
Bio Roundup: #JPM18, Axovant’s Fall, CRISPR Caveat, Impact M&A & More 01/12/18 National
LendingPoint Adds Point-of-Sale Financing with LoanHero Buyout 01/11/18 San Diego
Notes From the JPM ’18 Vortex: Gene Therapy’s Reckoning and Lonely Cabs 01/11/18 National
SD Venture Funding Tops $1.9B in 2017; and Q4 Top 10 Deals 01/10/18 San Diego
Venture Activity Comes to (Unicorn) Point in 2017, and Top 10 Deals 01/09/18 National
After 2nd Bet on Familiar Drug, Impact Bio Lands $1B Celgene Buyout 01/07/18 San Diego
Bio Roundup: Trump, Gottlieb, Gene Therapy Prices, IPO Hopes & More 01/05/18 National
Six West Coast Tech Leaders Share Top Developments of 2017 01/03/18 Seattle
Genalyte Takes Aim at Lab Testing Giants with Cloud-Based Service 01/03/18 San Diego
Clean Energy Entrepreneur Desai on Tech’s Pitfalls & Promise in 2017 01/03/18 Texas
First U.S. Gene Therapy, Approved for Vision Loss, to Cost $850,000 01/03/18 National
In Quest to Drug RNA With Small Molecules, Expansion Pulls In $55M 01/03/18 San Diego
Trump v. Drug Makers? And 6 More Burning Biopharma Questions for 2018 01/02/18 National
Six Useful Things You Can Do With Your New Smart Speaker 01/02/18 National
Family & Kids’ Advocate Shum Preston on the Tech Backlash of 2017 01/02/18 San Francisco
Houston Investor Murthy Reflects on Tech’s High & Low Points in 2017 12/29/17 Texas
Security Evangelist Tony Anscombe on the Tech Backlash of 2017 12/29/17 San Diego
UTD’s Guengerich on the Promise and Peril of Tech Innovation in 2017 12/28/17 Texas
WatchHerWork CEO Hamilton: “We Are All Ready for Tech to Grow Up” 12/27/17 Texas
Despite Scandal-Filled Year, Mark Cuban Says “Tech Is Just Tech” 12/26/17 Texas
Cybersecurity Expert Ash Mozano on the Tech Backlash of 2017 12/26/17 San Diego
Roche Bets $1.7B More on Precision Oncology With Ignyta Deal 12/22/17 San Diego
Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More 12/22/17 National
San Diego Life Sciences 2022: Photos and Takeaways 12/19/17 San Diego
Bio Roundup: Tax Cuts, a Funding Rush, Hemophilia Questions & More 12/15/17 National
Gene Therapy Advances, But Hemophilia Is No Easy Target 12/13/17 National
ASH 2017 Highlights: CAR-T Competition, Myeloma, Hemophilia & More 12/11/17 National
Page 1 of 63 next page »